Physician

Jeffrey Dean Davis, MD

According to 2025 Medicare claims, Jeffrey Davis, MD (NPI: 1891758140) practices internal medicine in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is MARTHA JEFFERSON MEDICAL GROUP LLC (NPI: 1275720559; TIN: 261126956) and primary practice location at 22903-4977. Davis is affiliated with the Sentara Accountable Care Organization, LLC (ACO ID: A4868), participating under the MSSP model.

Davis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 629 traditional Medicare patients, billed 3,559 HCPCS/CPT codes, and received $222,490 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,026 prescription claims across 808 beneficiaries totaling $624,482 in drug costs, led by Eliquis (Apixaban). DME data shows 99 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $424,350 to $624,482. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,311 to $7,732.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	756	8,109	$212,970
2016	732	6,818	$195,693
2017	731	7,263	$185,369
2018	731	6,734	$183,364
2019	726	3,817	$153,454
2020	692	3,331	$143,538
2021	738	3,424	$175,508
2022	652	3,279	$180,631
2023	650	3,285	$186,949
2024	629	3,559	$222,490

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	571	8,138	$424,350
2016	611	8,394	$449,085
2017	628	7,931	$433,515
2018	638	7,703	$437,938
2019	680	7,300	$405,843
2020	655	7,284	$391,960
2021	722	7,526	$458,561
2022	763	7,827	$553,694
2023	771	8,009	$582,463
2024	808	9,026	$624,482

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	105	311	$4,796
2016	98	288	$4,459
2017	60	277	$8,757
2018	54	201	$5,781
2019	44	161	$5,972
2020	37	132	$7,049
2021	38	166	$4,149
2022	24	152	$4,026
2023	24	112	$2,338
2024	18	99	$5,043

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	487	487	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	517	863	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	274	381	$61
G0008	Administration of influenza virus vaccine	124	126	$31
36415	Insertion of needle into vein for collection of blood sample	418	609	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	156	9,266	$172,706
Ozempic	Semaglutide	89	3,898	$98,003
Jardiance	Empagliflozin	54	3,600	$65,746
Trulicity	Dulaglutide	20	1,402	$43,851
Farxiga	Dapagliflozin Propanediol	22	1,740	$31,763

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$4,119
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	18	49	$830
A4256	Normal, low and high calibrator solution / chips	N	N/R	15	$51
A4259	Lancets, per box of 100	N	N/R	22	$43

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Dean Davis, MD?

Tedicare shows public-source Medicare data for Jeffrey Dean Davis, MD (NPI 1891758140), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Dean Davis, MD have ACO affiliation data?

Jeffrey Dean Davis, MD is shown with ACO affiliation data for Sentara Accountable Care Organization, LLC (MSSP, ACO ID A4868).

What billing organization is linked to Jeffrey Dean Davis, MD?

Jeffrey Dean Davis, MD is linked to MARTHA JEFFERSON MEDICAL GROUP LLC (billing NPI 1275720559) in the available physician profile data.

Does Jeffrey Dean Davis, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.